> PPD and inVentiv Health are among the last big CROs that haven't gone public. Outsourcing-Pharma takes a look at their businesses and the odds either will take the plunge on an IPO. Story
> CRO Venn Life Sciences signed a $1.8 million deal to run a European trial for an undisclosed U.S. drug developer. More